Table 4.
Freedom from biochemical failure, local failure, distant metastases, and overall survival at 3 and 5 years
| Group | FFBF | FFLF | DMFS | OS | ||||
|---|---|---|---|---|---|---|---|---|
| 3 years | 5 years | 3 years | 5 years | 3 years | 5 years | 3 years | 5 years | |
| All patients | 82.6 | 74.6 | 94.4 | 90.2 | 87.8 | 81.7 | 96.3 | 88.1 |
| RAD | 88.6 | 83.7 | 97.3 | 97.3 | 91.9 | 87.1 | 97.3 | 87.3 |
| ART | 80.5 | 73.8 | 97.1 | 90.0 | 91.6 | 88.1 | 94.7 | 88.6 |
| SRT | 78.4 | 65.3 | 88.5 | 83.6 | 79.4 | 68.8 | 97.1 | 87.6 |
RAD, radical radiotherapy; ART, adjuvant radiotherapy; SRT, salvage radiotherapy; FFBF, freedom from biochemical failure; FFLF, freedom from local failure; DMFS, distant metastasis-free survival; OS, overall survival.